Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy: A double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064)
O’Brien, Mary E.R., Gaafar, Rabab, Hasan, Baktiar, Menis, Jessica, Cufer, Tanja, Popat, Sanjay, Woll, Penella J., Surmont, Veerle, Georgoulias, Vassilis, Montes, Ana, Blackhall, Fiona, Hennig, Ivo, ScVolume:
51
Langue:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2015.04.026
Date:
August, 2015
Fichier:
PDF, 1.31 MB
english, 2015
File converter
Plus de résultats de recherche
More benefits 
